domingo, 22 de julio de 2012

Colorectal Cancer: Is Your Patient at High Risk?

Colorectal Cancer: Is Your Patient at High Risk?



Colorectal Cancer: Is Your Patient at High Risk?
E-mailPrint
Learn to identify patients at increased risk for hereditary colorectal cancer (CRC) syndromes while earning CME with this free, web-based educational program from NCHPEG and AMA.
Sample Image
Colorectal cancer (CRC) is the third most common cancer site in the United States. While the average person has a 5% lifetime risk for developing CRC, individuals with hereditary cancer syndromes have up to 100% risk. Health providers in all settings can help identify individuals and families at increased risk for these syndromes through asking the right questions.
This program from NCHPEG and AMA allows providers to earn CME by providing the opportunity to learn and practice skills related to risk assessment, genetic testing, communication, and management of hereditary cancer syndromes.

Who is the program for?

The program was originally developed for primary care physicians, with secondary audiences of gastroenterologists, surgeons, and oncologists. The content is also appropriate for nurses, physician assistants, and genetic counselors.

How much does the program cost?

The program is free for anyone to use. Registration is required to allow us to verify your email address and to track your completion of the pre- and post-test for continuing education programs. The program is self-directed, meaning that you can go through it on your own time and return as many times as you wish.

Are CME or Continuing Education Credits Available?

A choice between two types of CME, traditional CME and performance improvement (PI) CME, are available, free of charge, through the AMA for physicians and physician assistants who complete the program and pre- and post-tests. We are currently looking into providing CE/CEU for nurses and genetic counselors. This page will be updated when we have more information. The program is still accessible for healthcare providers who do not wish to apply for CME credit.

What is PI-CME?

Performance Improvement (PI) CME is a type of CME that incorporates performance assessment. In addition to completing the educational program, physicians who choose the PI-CME option review a small number of charts before and after taking the program to assess their own behavior with regards to assessing risk for hereditary CRC syndromes. For this added effort, physicians receive additional CME credit-20 CME credits for completing the PI-CME option compared to 6 credits for the enduring CME. For more information about PI-CME, please read this article in NCHPEG's 2012 Spring Newsletter.
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians.
Traditional (Enduring) CME: The American Medical Association designates this enduring material for a maximum of 6.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Performance Improvement CME: The American Medical Association designates this performance improvement activity for a maximum of 20.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Funding

This program was supported in part by unrestricted educational grants from Myriad Genetics and Humana, and by the Veterans Health Administration (Contract #VA200P0034) and American Medical Association.

Interested in taking the program? The course is available in both an enduring format and a performance improvement format for CME credit. Individuals who do not plan to apply for CME should register for the enduring course. Click on the links to read more about each option and register.
Interested in learning more? Read the Introduction to the program, which includes the learning objectives and other information, and see the press release.
Have other questions? Contact Kate Reed.

No hay comentarios:

Publicar un comentario